The Treatment Action Campaign (TAC) says it’s ready to litigate against the Gauteng Health Department should it not clear its outstanding debt to suppliers. The TAC adds that the closure of health laboratories in Gauteng and KwaZulu-Natal has severely impacted on people who are HIV-positive and those with TB. Chairperson of the Treatment Action Campaign, Nonkosi Khumalo says the closure of health laboratory services impacts on patients on Anti-retroviral treatment (ARVs) and those who need to be tested for TB. Blood tests are not being done due to the closures. Khumalo says some health care facilities are unable to initiate new patients on ARV treatment because they can’t get their blood tests to laboratories.

With global funding for HIV/AIDS on the decline, Zimbabwe's innovative AIDS levy - a 3 percent tax on income - has become a promising source of funding for the country, with a dramatic increase in revenue collected in the past two years. The levy was introduced in 1999 to compensate for declining donor support, but low salaries and the poor performance of industry meant not enough money had been collected - until recently. According to recently published audited financial statements for the year ending 31 December 2010, a total of US$20.5 million was collected in 2010 against $5.7 million the previous year.

Côte d’Ivoire’s leprosy programme was consistently under-funded during the civil war (2002-2007) and last year’s political turmoil, say health practitioners, leading to a loss of expertise in terms of detecting or treating the disease. Not considered a public health priority, the government and donors de-prioritized the leprosy fight over the past decade, with funding dropping to 30 per cent of the original total, according to Alain de Kersabiec, Côte d’Ivoire and Benin representative for French NGO the Follereau Foundation (FRF), which helps treat existing and new leprosy patients around the country.